[Transitory increase in splenic FDG uptake secondary to the administration of granulocyte colony stimulating factor (G-CSF)].
Ubieto
M A
MA
Unidad de Medicina Nuclear, Centro Hospitalario Quirón, Zaragoza, España. mnuclear.zar@quiron.es
Banzo
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016477:Artifacts; D001853:Bone Marrow / Q000000981:diagnostic imaging; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics*; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology* / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013154:Spleen / Q000000981:diagnostic imaging*; D014018:Tissue Distribution / Q000187:drug effects; D055815:Young Adult
D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D016179:Granulocyte Colony-Stimulating Factor